JANX stock

Janux Therapeutics Inc (JANX) financials · rev $10.0M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Janux Therapeutics Inc (JANX) rev $10.0M.

Cached annual income statement
LineFY2025FY2024
Revenue$10.0M$10.6M
Operating Income-$157.7M-$98.8M
Net Income-$113.6M-$69.0M
EPS (Diluted)-$1.83-$1.28
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.00B$1.06B
Current Assets$975.9M$1.03B
Cash & Equivalents$52.3M$430.6M
PP&E$3.85M$4.86M
Total Liabilities$44.7M$38.7M
Current Liabilities$25.0M$17.5M
Shareholders' Equity$956.8M$1.02B
Retained Earnings-$351.4M-$237.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$82.2M-$43.8M
CapEx$1.04M$359.0K
Investing Cash Flow-$301.0M-$258.0M
Financing Cash Flow$4.95M$713.2M
Free Cash Flow-$83.3M-$44.2M
These statements as JSON? API free 100/day

FAQ

What is JANX P/E and revenue?

Janux Therapeutics Inc (JANX) rev $10.0M.

What is JANX revenue?

Janux Therapeutics Inc last cached revenue is $10.0M (FY2025).

Is JANX profitable?

Janux Therapeutics Inc last cached net income is -$113.6M (FY2025).

What are JANX total assets?

Janux Therapeutics Inc last cached total assets are $1.00B (FY2025).

What is JANX free cash flow?

Janux Therapeutics Inc last cached free cash flow is -$83.3M (FY2025).

Not investment advice. Cached statements, not a live tape.